Ovarian cancer |
Epithelial |
Serous |
High-grade |
90% of serous ovarian cancer |
[10,12,13,14,15] |
Generally diagnosed in older women |
Present at advanced stages |
Have poor prognosis (10-year survival rate of 30%) |
Originates in the ovary, fallopian tube, and others |
Have TP53 and BRCA mutation |
50% of tumors have homologous recombination deficiencies |
Low-grade |
Usually diagnosed in younger women |
[10,12,14,16,17] |
Grow slowly |
Have a better prognosis than high-grade serous carcinoma |
Originates in ovary |
Endometrioid |
Low-grade |
Chemosensitive |
[10,18,19] |
Generally diagnosed in the early stage |
Originates in endometriosis |
Has better prognosis |
Mucinous |
Low-grade |
Most uncommon cancer in epithelial ovarian cancer |
[10,19,20,21] |
Associated with metastasis from the gastrointestinal tract |
Most patients are diagnosed with stage I |
Clear cell |
Low-grade |
Relatively have a good prognosis |
[1,10,19,22] |
Generally diagnosed in the early stage |
Have resistance to platinum-based chemotherapy in advanced stage |
Non-epithelial |
Germ cell |
- |
3% of ovarian cancer |
[1,10,23,24] |
Have obvious makers of tumor |
Diagnosed at a young age (10~30 years old) |
Histologically like men’s germ cell tumors in the testes |
Sex cord-stromal |
- |
Under 2% of ovarian cancer |
[25,26] |
Generally diagnosed in the early stage |
Smoking decreases the risk of the tumor |
Rarely have malignance |